Aclarion Expands CLUE Trial to New Jersey with Dr. Justin Kubeck Joining the Network of Surgeons
Aclarion expands CLUE Trial to New Jersey with Dr. Justin Kubeck joining the network of surgeons. The trial aims to identify how often Nociscan's AI data changes the initial treatment plan for patients with chronic low back pain.
This news matters as it highlights the potential impact of Nociscan's AI data on the initial treatment plan for patients with chronic low back pain. It also emphasizes the importance of real-world evidence in driving early payer coverage decisions for emerging diagnostic tools.
